https://www.selleckchem.com/products/BEZ235.html
Seven studies encompassing 485 WUS/UNK patients were included in a pooled analysis with a 2.1% incidence of sICH. In our meta-analysis, three studies compared NCCT-based treated WUS/UNK patients with SW patients with no difference in rate of hemorrhage 2.1% vs 3.4% (OR 1.01; 95% confidence interval 0.45-2.28). Our single-center analysis and meta-analysis suggest that tPA can be safely administered based on NCCT with comparable rates of sICH for select WUS/UNK stroke patients. Our single-center analysis and meta-analysis suggest that tPA
Like
Comment
Share
